1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities And Challenges Analysis (Droc)
6.1 Market Drivers
6.1.1 Increase in Bioinformatics Research
6.1.2 Increasing Number of Clinical Studies in Pharmacogenomics and Pharmacokinetics
6.1.3 Growth of Drug Designing, Disease Modeling, and Personalized Medicine
6.2 Market Restraints
6.2.1 Lack of Trained Professional
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Application
7.1.1 Cellular & Biological Simulation
7.1.1.1 Computational Genomics
7.1.1.2 Computational Proteomics
7.1.1.3 Pharmacogenomics
7.1.1.4 Other Cellular and Biological Simulations (Transcriptomics/Metabolomics)
7.1.2 Drug Discovery and Disease Modelling
7.1.2.1 Target Identification
7.1.2.2 Target Validation
7.1.2.3 Lead Discovery
7.1.2.4 Lead Optimization
7.1.3 Preclinical Drug Development
7.1.3.1 Pharmacokinetics
7.1.3.2 Pharmacodynamics
7.1.4 Clinical Trials
7.1.4.1 Phase I
7.1.4.2 Phase II
7.1.4.3 Phase III
7.1.5 Human Body Simulation Software
7.2 By Tools
7.2.1 Databases
7.2.2 Infrastructure(Hardware)
7.2.3 Analysis Software & Services
7.3 By Services
7.3.1 In-House
7.3.2 Contract
7.4 By End - User
7.4.1 Academics
7.4.2 Industry
7.4.3 Commercial
7.5 By Geography
7.5.1 North America
7.5.1.1 United States
7.5.1.2 Canada
7.5.1.3 Mexico
7.5.2 Europe
7.5.2.1 France
7.5.2.2 United Kingdom
7.5.2.3 Germany
7.5.2.4 Italy
7.5.2.5 Spain
7.5.2.6 Rest of Europe
7.5.3 Asia-Pacific
7.5.3.1 India
7.5.3.2 China
7.5.3.3 Japan
7.5.3.4 Australia
7.5.3.5 South Korea
7.5.3.6 Rest of APAC
7.5.4 Middle East & Africa
7.5.4.1 GCC
7.5.4.2 South Africa
7.5.4.3 Rest of Middle East & Africa
7.5.5 South America
7.5.5.1 Brazil
7.5.5.2 Argentina
7.5.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers And Acquisition Analysis
8.2 Agreements, Collaborations & Partnerships
8.3 New Products Launches
9. Key Players
9.1 Dassault Systemes
9.2 Certara
9.3 Chemical Computing Group Inc.
9.4 Compugen Ltd
9.5 Rosa & Co. LLC (Acquired Entelos)
9.6 Genedata AG
9.7 Insilico Biotechnology AG
9.8 Leadscope Inc
9.9 Nimbus Discovery Llc
9.10 Strand Life Sciences
9.11 Schrodinger
9.12 Simulation Plus Inc
10. Future of the Market

Dassault Systemes
Certara
Chemical Computing Group Inc.
Compugen Ltd
Rosa & Co LLC
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery LLC
Strand Life Sciences
Schrodinger
Simulation Plus Inc.